First-line single-agent chemotherapy for patients with recurrent or metastatic gastric cancer with poor performance status.

Authors:
Hwang JE; Kim HN; Kim DE; Shim HJ; Bae WK and 3 more

Journal:
Exp Ther Med

Publication Year: 2012

DOI:
10.3892/etm.2012.644

PMCID:
PMC3501373

PMID:
23170106

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Exp Ther Med

Abbreviation: Exp Ther Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A novel animal model of abdominal aortic aneurysm by mechanical injury.
Kim SH; Park JH; Kim DH and 3 more (2024) - Transparency Score: 3/6
Antibiotic administration aggravates asthma by disrupting gut microbiota and the intestinal mucosal…
Xu CL; Wang C; Li GB and 3 more (2024) - Transparency Score: 4/6
Anti‑osteoclastogenic effect of fermented mealworm extract by inhibiting RANKL‑induced NFATc1 actio…
Ham JR; Lee MK. (2024) - Transparency Score: 3/6
Biochanin A inhibits endothelial dysfunction induced by IL‑6‑stimulated endothelial microparticles …
Liu J; Lin C; Li B and 8 more (2024) - Transparency Score: 3/6
CHL1 inhibits cell proliferation, migration and invasion by regulating the NF‑κB signaling pathway …
Bao M; Li S; Zhu Y and 3 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
0/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025